5 Ways To Turn Pharmaceutical Ambitions into Market Impact

For many pharmaceutical companies, market access is a cornerstone of strategic growth. The steady increase in global demand for healthcare products presents new opportunities for healthcare and MedTech players to capitalise and establish themselves in new markets.

But ambitious market access strategies, founded on expertise and sustainability, are threatened by a complex operating environment beset with geopolitical risk and regulatory uncertainty. To get supply chains up and running in new markets, and to meet the time-critical needs of patients, pharmaceutical companies need reliable logistics partners capable of navigating regulations, managing customs, building local partnerships and completing last-mile delivery.

The challenge is not global strategy, but local execution. At LogiPharma 2026, our healthcare experts explained five practical steps for pharmaceutical companies to take to bridge the gap from strategic ambition to measurable market impact.

1. Design For Access, Not Just Demand

For pharmaceutical companies looking to expand into new markets, ambition is constrained not by demand, but by fragmentation. The healthcare value chain, from manufacturing to transportation and last-mile delivery, can face conditions of structural disruption if key processes operate in siloes rather than as part of an integrated logistics strategy. Such disruption can break the pharmaceutical cold-chain, causing lengthy delays and compromising delivery.

Effective market access depends on connecting ports, inland logistics, regulatory navigation and last‑mile delivery into a single, integrated flow. In Africa, we supported a pharmaceutical customer to unlock over $16 million in new sales by overcoming infrastructure and access barriers – enabling direct delivery to a range of new customers.

The lesson is clear: access is not a commercial issue to be solved downstream, but an operational one that must be designed into the supply chain from the outset.

2. Manage Disruption by Prioritising Optionality

The operating environment in healthcare logistics is marked by frequent disruption and crisis.  Indeed, our World Without Logistics: Healthcare report found that, between 2022 and 2025, the average cost of each disruption to a healthcare cargo owner was $595,000 with cumulative annual losses exceeding $11 billion. Supply chain shocks can cause what appear first as minor delays to rapidly escalate into product shortages, procedure cancellations, and - in the worst case - total breakdown of market access.

The most resilient market access strategies are those that prioritise optionality. Multimodal logistics networks present new options when traditional transit routes are blocked, and strategic pre-positioning of inventory allow for swift responses to crises and shortages across the globe. And the most resilient strategies are underpinned by cutting-edge technology that provides visibility throughout the journey.

Managing disruption is therefore less about crisis response and more about proactive network design that assumes instability as the norm. 

3. Embed Local Expertise into Global Networks

The resilient pharmaceutical supply chains that produce measurable market impact are backed not only by smart strategy, but by on-the-ground operational excellence at every step of the process. Even with strong visibility, poorly aligned handovers or weak on‑the‑ground capabilities can undermine continuity of care.

Throughout the pharmaceutical supply chain, we deliver the local expertise required to execute market access strategies. In one recent example of an emergency medical delivery, our efficient customs clearance processes reduced wait times from 3 days to 24 hours, and cut the entire transit time by 3 days. And last-mile logistics are equally key - coordinated delivery, installation and returns are often the final piece of an effective market access strategy.

4. Build Specialised, Compliant Solutions

For pharmaceutical companies, successful market access depends on logistics solutions designed around the strict demands of regulated, temperature‑sensitive products.  

Our healthcare network combines a network of over 40 GDP-compliant cold chain storage facilities with regulatory compliance and real-time shipment visibility to ensure end-to-end delivery of time- and temperature-sensitive products. Integrated logistics allow healthcare companies to put patient outcomes at the heart of their service, without the risk of avoidable disruption. Just as critical is local regulatory expertise, which helps navigate complex approval, documentation and clearance requirements in new and emerging markets.  

By tailoring storage, transport and compliance processes to different pharmaceutical products - from generics to biologics - companies can reduce risk, avoid costly delays and enter new markets with confidence, ensuring medicines reach patients on time.

5. Cultivate Strong Logistics Partnerships

Finally, market access hinges on trusted partnerships with strong local presence. Global scale is important, but efficient market access is not possible without strong compliance, deep regulatory understanding and execution capability. The right partners mitigate the risk of market entry, transforming it into a repeatable, scalable process.

Our global network of owned infrastructure and local experts, who draw on years of experience operating on the ground in the most buoyant pharmaceutical markets, are the backbone of our partnerships with pharmaceutical and healthcare companies. From freight forwarding to contract logistics, our capabilities open new doors and help partners capitalise on new market opportunities.

Healthcare supply chains now sit at the heart of clinical reliability and patient trust. Every disruption has real‑world consequences, but integrated planning and local implementation can mitigate risk and drive scalable market access strategies. From small, targeted shifts such as inventory repositioning, to structural redesigns of healthcare supply chains, we're helping businesses expand into high-potential markets with confidence, driving growth and delivering measurable outcomes for patients.  

Find out more about our Market Access solutions.